https://www.selleckchem.com/products/VX-809.html
Discussion Our study will advance the field in two ways 1) by providing evidence about the effectiveness of pharmacy liaisons who also function as patient navigators; and 2) by de-implementing patient navigators. Patients in the enhanced usual care arm will no longer receive the services of a clinic-based patient navigator. In addition, our study includes a novel collaboration with a community-based organization, and focuses on an intermediate-cost patient population, rather than the most costly patient population.Background Few studies
Me gusta
Comentario
Compartir
